2014
DOI: 10.1186/1472-6882-14-115
|View full text |Cite
|
Sign up to set email alerts
|

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs

Abstract: BackgroundComplementary and alternative medicine is often used by patients with malignant glioma. Although several interactions of various alternative agents with chemotherapy are known, none has been described for temozolomide so far.Case presentationWe report the case of severe liver toxicity with jaundice during radiochemotherapy with temozolomide likely due to interaction with a popular Chinese herbal formula after surgery for glioblastoma. After cessation of the herbal formula as well as the chemotherapy … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 9 publications
0
14
0
Order By: Relevance
“…Patient choices regarding healthcare often do not align with the tenets of the current medical paradigm. Four documents contained strong language to support autonomy and respectful discussion with patients such as “we hope to inspire the discussion about the safety of any herbal formulas in combination with cytotoxic therapies and encourage physicians to seek faithful conversations dealing with the use of CAM in cancer patients” [ 59 ] (p. 3) and “it is our professional duty to increase our understanding of alternative medicine and to provide unbiased information without sounding judgmental or indifferent” [ 60 ] (p. 1653). Seven documents contained language with the opposite tone including “the fact that this patient was a registered nurse also did not prevent her from combining medications, although it is arguable that her judgement may have been subtly affected by the TBI” (traumatic brain injury) [ 61 ] (p. 363) and “the patient was informed that discontinuation of SJW (St. John’s wort) would be next if her symptoms fail to resolve” [ 62 ] (p. 683).…”
Section: Discussionmentioning
confidence: 99%
“…Patient choices regarding healthcare often do not align with the tenets of the current medical paradigm. Four documents contained strong language to support autonomy and respectful discussion with patients such as “we hope to inspire the discussion about the safety of any herbal formulas in combination with cytotoxic therapies and encourage physicians to seek faithful conversations dealing with the use of CAM in cancer patients” [ 59 ] (p. 3) and “it is our professional duty to increase our understanding of alternative medicine and to provide unbiased information without sounding judgmental or indifferent” [ 60 ] (p. 1653). Seven documents contained language with the opposite tone including “the fact that this patient was a registered nurse also did not prevent her from combining medications, although it is arguable that her judgement may have been subtly affected by the TBI” (traumatic brain injury) [ 61 ] (p. 363) and “the patient was informed that discontinuation of SJW (St. John’s wort) would be next if her symptoms fail to resolve” [ 62 ] (p. 683).…”
Section: Discussionmentioning
confidence: 99%
“…The copyright holder for this preprint (which was this version posted March 30, 2018. ; https://doi.org/10.1101/292342 doi: bioRxiv preprint with numerous protein targets involved in various diseases, including cancer, metabolic, neurodegenerative, inflammation and microbial diseases (39). However, to be succeed in clinical application, several problems are still to be solved including, solubility, stability, potential hepatotoxicity (40,41), inadequate target specificity and potential antagonizing effects in combination therapy (42,43). ADS-J1 exerts limited oxidative capability.…”
Section: Discussionmentioning
confidence: 99%
“…The antioxidant function or the auto-oxidation ability of EGCG might be responsible for its ability to interfere with a number of amyloid fibrils and to interact with numerous protein targets involved in various diseases, including cancer, metabolic, neurodegenerative, inflammation and microbial diseases (39). However, to be succeed in clinical application, several problems are still to be solved including, solubility, stability, potential hepatotoxicity (40,41), inadequate target specificity and potential antagonizing effects in combination therapy (42,43). ADS-J1 exerts limited oxidative capability.…”
Section: Discussionmentioning
confidence: 99%